Sylvester Comprehensive Cancer Center, University of Miami
South Florida's NCI-designated cancer centre, serving a largely Hispanic catchment, with strengths in myeloma, myeloid malignancies and proton therapy.
NCI-designated in 2019, Sylvester is the University of Miami's cancer centre and the only NCI-designated centre in South Florida, with a catchment that is majority Hispanic and a gateway to the Caribbean and Latin America. Director Stephen Nimer is a leukaemia and epigenetics researcher; Ola Landgren's myeloma programme focuses on MRD-driven treatment strategies. The Dwoskin Proton Therapy Center added proton beam therapy to the region, and Sylvester's Firefighter Cancer Initiative and Game Changer mobile screening vehicles are notable community programmes. It runs a substantial phase 1 unit.
- Multiple myeloma (MRD-guided therapy)
- Myeloid malignancies
- Proton therapy
- Community screening
Pages like this
not linked directly; found by shared links- InstitutionVCU Massey Comprehensive Cancer Center
Shares Trials do not represent the people who get cancer, Multiple myeloma, Acute myeloid leukaemia.
- InstitutionUniversity of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
Shares Proton therapy, Trials do not represent the people who get cancer, Multiple myeloma.
- InstitutionCancer Center Clínica Universidad de Navarra / CIMA
Shares Proton therapy, Minimal / molecular residual disease (MRD), MRD / molecular residual disease testing, Multiple myeloma.
- TechnologyMultiparameter flow cytometry MRD
Shares Myelodysplastic syndromes / neoplasms (MDS), Minimal / molecular residual disease (MRD), MRD / molecular residual disease testing, Multiple myeloma.
- InstitutionMontefiore Einstein Comprehensive Cancer Center
Shares Myelodysplastic syndromes / neoplasms (MDS), Trials do not represent the people who get cancer, Acute myeloid leukaemia.
- IdeaFix the neutrophil count rule that excludes many people of African ancestry
Shares Trials do not represent the people who get cancer, Multiple myeloma.
- InstitutionRoyal Adelaide Hospital
Shares Proton therapy, Acute myeloid leukaemia.
- ProductTreosulfan
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia.